Jeffrey Gersch
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 13
- Hepatitis B Virus Studies 13
- Liver Disease Diagnosis and Treatment 5
-
- Hepatitis C virus research 7
- Hepatitis Viruses Studies and Epidemiology 1
- Co-authors
- Gavin Cloherty (13 shared papers)Mary C. Kuhns (9 shared papers)Emily K. Butler (3 shared papers)Bo Wang (2 shared papers)Ivana Carey (4 shared papers)Anne L. McNamara (3 shared papers)Geoffrey Dusheiko (3 shared papers)Ka‐Cheung Luk (4 shared papers)
- Journals
- Journal of Hepatology (4 papers)Hepatology (3 papers)Scientific Reports (2 papers)Emerging infectious diseases (1 paper)Hepatology Communications (1 paper)
- Partner nations
- United StatesUnited KingdomCameroon
In The Last Decade
Jeffrey Gersch
14 papers receiving 402 citations
Peers
Comparison fields: 5 of 22
- Hepatology 223
- Epidemiology 381
- Infectious Diseases 22
- Virology 3
- Business and International Management 1
Countries citing papers authored by Jeffrey Gersch
This map shows the geographic impact of Jeffrey Gersch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Gersch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Gersch more than expected).
Fields of papers citing papers by Jeffrey Gersch
This network shows the impact of papers produced by Jeffrey Gersch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Gersch. The network helps show where Jeffrey Gersch may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Gersch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 119 | |
| 2 | 2019 | 118 | |
| 3 | 2020 | 58 | |
| 4 | 2020 | 58 | |
| 5 | 2018 | 16 | |
| 6 | 2017 | 11 | |
| 7 | 2020 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2019 | 3 | |
| 11 | HBV serum DNA and RNA levels in nucleos(t)ide analogue-treated or untreated patients during chronic and acute infection | 2018 | 2 |
| 12 | 2019 | 2 | |
| 13 | 2019 | 1 | |
| 14 | 2019 | 1 |
About Jeffrey Gersch
Jeffrey Gersch is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 409 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Malaria Research and Control (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper), Mosquito-borne diseases and control (1 paper), Vibrio bacteria research studies (1 paper) and Viral Infections and Outbreaks Research (1 paper). The work is most often cited by research in Hepatology (223 citations), Epidemiology (381 citations), Infectious Diseases (22 citations), Virology (3 citations) and Business and International Management (1 citation). Jeffrey Gersch has collaborated with scholars based in United States, United Kingdom and Cameroon. Frequent co-authors include Gavin Cloherty, Mary C. Kuhns, Emily K. Butler, Bo Wang, Ivana Carey, Anne L. McNamara, Geoffrey Dusheiko, Ka‐Cheung Luk, Vera Holzmayer and Lung‐Yi Mak. Their work appears in journals such as Journal of Hepatology, Hepatology, Scientific Reports, Emerging infectious diseases and Hepatology Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.